Hino, Japan

Masahiro Tsuchimoto

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Teijin Limited. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Tsuchimoto. Retrieved from https://idiyas.com/inventor/masahiro-tsuchimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Tsuchimoto: Innovator in Pharmaceutical Compositions

Introduction

Masahiro Tsuchimoto is a notable inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gout and hyperuricemia. His innovative work has led to the development of new compounds that hold promise for medical applications.

Latest Patents

Tsuchimoto holds a patent for 2-arylthiazole derivatives and pharmaceutical compositions thereof. This patent focuses on pharmaceutical compositions that contain 2-arylthiazole derivatives as an active ingredient. These compounds are designed to treat conditions such as gout or hyperuricemia, showcasing Tsuchimoto's commitment to advancing medical science.

Career Highlights

Masahiro Tsuchimoto is associated with Teijin Limited, a company known for its dedication to innovation in various sectors, including pharmaceuticals. His work at Teijin has allowed him to explore and develop new therapeutic solutions that can improve patient outcomes.

Collaborations

Throughout his career, Tsuchimoto has collaborated with esteemed colleagues such as Yoshio Osada and Hisashi Fukushima. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Masahiro Tsuchimoto's contributions to the field of pharmaceuticals, particularly through his patent on 2-arylthiazole derivatives, highlight his role as an innovator. His work continues to impact the treatment of gout and hyperuricemia, demonstrating the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…